Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Prevention of Irinotecan Induced Diarrhea by Probiotics
Phase 3
Completed
- Conditions
- DiarrheaCancer
- Interventions
- Drug: Probio-Tec® BG-VCap-6.5Drug: Placebo
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- S&D Pharma SK s.r.o.
- Target Recruit Count
- 233
- Registration Number
- NCT02819960
- Locations
- 🇸🇰
National Cancer Institute, Bratislava, Slovakia
Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients
Phase 2
- Conditions
- Febrile NeutropeniaNeutropeniaInfection in an Immunocompromised HostCancer
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- S&D Pharma SK s.r.o.
- Target Recruit Count
- 120
- Registration Number
- NCT02544685
- Locations
- 🇸🇰
University Children's Hospital Banska Bystrica, Banska Bystrica, Slovakia
News
No news found